# A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease

> **NCT07319598** · PHASE4 · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Interstitial Lung Disease (ILD)
- Connective Tissue Disease-associated Interstitial Lung Disease

## Interventions

- **DRUG:** Tetrandrine Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07319598
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-02
- **Primary completion:** 2026-10-15
- **Final completion:** 2027-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07319598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07319598, "A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07319598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*